0001209191-23-039960.txt : 20230627 0001209191-23-039960.hdr.sgml : 20230627 20230627180124 ACCESSION NUMBER: 0001209191-23-039960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandborn William J. CENTRAL INDEX KEY: 0001923805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 231048705 MAIL ADDRESS: STREET 1: C/O VENTYX BIOSCIENCES, INC. STREET 2: 662 ENCINITAS BLVD. STE 250 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-23 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001923805 Sandborn William J. C/O VENTYX BIOSCIENCES, INC. 662 ENCINITAS BLVD, SUITE 250 ENCINITAS CA 92024 0 1 0 0 See Remarks 0 Common Stock 2023-06-23 4 M 0 10790 0.20 A 59179 D Common Stock 2023-06-23 4 S 0 2115 32.1002 D 57064 D Common Stock 2023-06-23 4 S 0 8675 32.8475 D 48389 D Common Stock 31175 I By Spouse Stock Option (Right to Buy) 0.20 2023-06-23 4 M 0 10790 0.00 D 2029-03-27 Common Stock 10790 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022. Represents the weighted average share price of an aggregate total of 2,115 shares sold in the price range of $31.51 to $32.4136. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 8,675 shares sold in the price range of $32.5854 to $33.5094. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Subject to the Reporting Person's spouse continuing to be a Service Provider (as defined in the Issuer's 2019 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019. President and Chief Medical Officer /s/ Christopher Krueger, as Attorney-in-Fact 2023-06-27